Stay updated on Nivolumab + Low Dose Radiotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Low Dose Radiotherapy Clinical Trial page.

Latest updates to the Nivolumab + Low Dose Radiotherapy Clinical Trial page
- Check2 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study record continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH banner announces updates about a terminology transition, stating that “Super Intelligence” is replacing “Artificial Intelligence” in some NIH content.SummaryDifference1%

- Check16 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study record content and navigation, indicating the URL is currently inaccessible.SummaryDifference17%

- Check65 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 on the page, indicating a new build with minor updates. This is a metadata/version change rather than a modification to core study page content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Low Dose Radiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Low Dose Radiotherapy Clinical Trial page.